Different immune responses identified in patients with COVID-19
Researchers identify differences in immune response in asymptomatic COVID-19 cases compared to those with severe symptoms
SCIENCE & TECHNOLOGY2021
sciencescience-technology
Showing results out of
Researchers identify differences in immune response in asymptomatic COVID-19 cases compared to those with severe symptoms
SCIENCE & TECHNOLOGY2021
sciencescience-technology
Discoveries at EMBL will help researchers to interpret one of the most common types of experiments in genomics and medical studies.
SCIENCE & TECHNOLOGY2020
sciencescience-technology
Scientists at EMBL Heidelberg have developed a new method, called Targeted Perturb-seq (TAP-seq), which increases the scale and precision of functional genomics CRISPR–Cas9 screens by orders of magnitude. Their method overcomes limitations in previous applications of single-cell RNA sequencing,…
SCIENCE & TECHNOLOGY2020
sciencescience-technology
EMBL’s Genomics Core Facility supports students participating in the annual iGEM competition.
SCIENCE & TECHNOLOGY2019
sciencescience-technology
Scientists develop high-throughput yeast single-cell RNA sequencing method
SCIENCE & TECHNOLOGY2019
sciencescience-technology
No results found